StonvexLoading…
StonvexStonvexStonvexCore line items from TDAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.30B | $2.51B | $2.66B | $2.95B |
Operating Income | $-1.27M | $-42.84M | $86.27M | $-33.60M |
Net Income | $1.75M | $-26.35M | $-27.79M | $-78.00M |
EPS (Diluted) | $0.01 | $-0.18 | $-0.20 | $-0.57 |
Total Assets | $1.84B | $2.04B | $2.18B | $2.39B |
Total Liabilities | $1.68B | $1.89B | $1.86B | $2.10B |
Cash & Equivalents | $90.21M | $106.30M | $100.18M | $94.25M |
Free Cash Flow OCF − CapEx | $62.90M | $50.78M | $56.46M | $-4.60M |
Shares Outstanding | 147.12M | 147.39M | 148.94M | 146.22M |